Skip to content
  • Sunday, 26 July 2026
  • 2:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Moving beyond the binary: how the convergence of small and large molecules is reshaping pharmaceutical R&D
Laboratory Automation & Robotics

Moving beyond the binary: how the convergence of small and large molecules is reshaping pharmaceutical R&D

Lana Keisha Mar 24, 2026 0

Pharmaceutical research and development is experiencing a profound transformation, marked by an unprecedented convergence of technological advancements, vast data streams,…

Read More
Clinical Diagnostics & Pathology

Revolutionary Blood Test Model Forecasts Alzheimer’s Symptom Onset, Reshaping Early Detection and Clinical Trial Strategies

Reynand Amr Wu Mar 19, 2026 0

Clinical laboratories across the globe are keenly observing a pivotal shift in neurodegenerative disease diagnostics, particularly with the escalating prominence…

Read More

Posts pagination

1 2 3
Texas A&M Researchers Develop Breakthrough Nasal Spray to Reverse Brain Aging and Combat Cognitive DeclineThe Galactic Center Excess and the Mystery of Two-Component Dark Matter: New Research Explains the Silence of Dwarf GalaxiesEClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data PlatformRubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ